Rucaparib population pharmacokinetics (PPK) and exposure-response (ER) analyses in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in TRITON2 Meeting Abstract


Authors: Chowdhury, S.; Patnaik, A.; Campbell, D.; Shapiro, J.; Bryce, A. H.; McDermott, R.; Sautois, B.; Vogelzang, N. J.; Bambury, R.; Voog, E.; Zhang, J.; Green, M.; Beltman, J.; Despain, D.; Simmons, A. D.; Watkins, S. P.; Golsorkhi, A.; Xiao, J.; Abida, W.
Abstract Title: Rucaparib population pharmacokinetics (PPK) and exposure-response (ER) analyses in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in TRITON2
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S533
End Page: S534
Language: English
ACCESSION: WOS:000573469100656
DOI: 10.1016/j.annonc.2020.08.918
PROVIDER: wos
Notes: Meeting Abstract: 659P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wassim Abida
    154 Abida